Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Calibration × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

pembrolizumab 1257 Specimen Handling 843 Carboplatin 816 Cyclophosphamide 802 Magnetic Resonance Spectroscopy 784 Cisplatin 699 Nivolumab 674 Paclitaxel 615 Radiotherapy 569 Gemcitabine 558 Biopsy 514 Bevacizumab 464 Dexamethasone 442 fludarabine 390 venetoclax 376 Docetaxel 375 Oxaliplatin 363 Fluorouracil 359 Capecitabine 351 atezolizumab 341 Rituximab 341 durvalumab 330 Doxorubicin 316 Pemetrexed 306 Radiosurgery 303 Ipilimumab 303 Drug Therapy 295 Standard of Care 292 Lenalidomide 279 Radiation 278

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483723 2026-03-19

PROGLYSOPK

Centre Hospitalier Universitaire, Amiens

Phase NA Recruiting

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡